Avidity Biosciences Inc works on the development of a new class of oligonucleotide-based therapies. These products aim to transform treatments worldwide by tackling previously untreatable diseases. The company operates globally from the United States.
Operating in the biotechnology sector, Avidity Biosciences Inc is focused on using its Antibody Oligonucleotide Conjugates (AOC) to combat genetic disorders. The RNA-targeted medicines created by Avidity offer a unique therapeutic approach, positioning the company as a reputable and innovative player in the industry.
Stay up to date on the share price of RNA by adding it to your eToro watchlist.